2024-10-26 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instrumentation, reagents, consumables, and software for research, analysis, and diagnostics.

**Performance Analysis:**

**1. Relative Performance:**
* **Cumulative Return:** TMO: 218.48%, VOO (S&P 500): 135.48%
* **Outperformance:** TMO has significantly outperformed the S&P 500 with a cumulative return difference of 83.0%. This places it in the 38.8th percentile of its historical performance range. 

**2. Recent Price Trends:**
* **Closing Price:** $557.38 (Last-market: $554.33)
* **Moving Averages:** 5-day: $583.47, 20-day: $597.74, 60-day: $605.37
* **Analysis:**  The stock is currently trading below all three moving averages, indicating a potential downward trend. However, the relatively close proximity to the 5-day moving average suggests some near-term support.

**3. Technical Indicators:**
* **RSI:** 27.0 - This indicates the stock is currently in oversold territory.
* **PPO:** -0.62 - This indicates a downtrend, although it's not very strong.
* **Delta_Previous_Relative_Divergence:** -16.87 - This signals a recent short-term decline in relative performance.
* **Expected Return:** 47.06% - This represents a potential long-term (2+ years) outperformance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

**Analysis:** The most recent earnings report (2024-08-02) showed a strong EPS of 4.05, exceeding analyst expectations.  Revenue was also strong, demonstrating consistent growth. This positive performance reinforces the company's solid financial position and future growth potential.

**5. News and Recent Issues:**

* **Earnings News:** The most recent earnings release was well received by analysts, with many reiterating buy recommendations and highlighting the company's strong growth prospects.
* **Market Outlook:** The market outlook for TMO remains positive, with analysts citing its strong competitive position, diversified product portfolio, and robust global presence. 
* **Analyst Opinions:**  Thermo Fisher Scientific Inc. enjoys a strong consensus of "Buy" ratings from analysts, with a 12-month price target that indicates further upside potential.
* **Performance Highlights:** The company continues to deliver on its growth strategy, expanding its market share through acquisitions, new product launches, and strategic partnerships. 

**6. Summary:**

* TMO has consistently outperformed the S&P 500 over the long term and currently presents a solid investment opportunity.
* Despite recent price weakness, the stock remains undervalued and shows strong earnings growth potential.
* The company's solid financial position, robust earnings performance, and favorable market outlook make it an attractive investment for both long-term and short-term investors.

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial professional before making any investment decisions. 
